RPL35A and hepatocellular carcinoma: Furthermore, elevated RPL35A expression has been reported in hepatocellular carcinoma (HCC) (13), and it has been identified as a key promoter of gastric cancer progression as well as a potential biomarker for tumor angiogenesis (14).However, the expression patterns, functional roles, and molecular mechanisms of RPL35A in lung cancer remain largely elusive.